BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26934825)

  • 1. Inhibition of cyclooxygenase-2 by NS398 attenuates noise-induced hearing loss in mice.
    Sun Y; Yu J; Lin X; Tang W
    Sci Rep; 2016 Mar; 6():22573. PubMed ID: 26934825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
    Zhong H; Willard M; Simons J
    Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the mGlu5 receptor and COX-2 protein in the mouse brain after imipramine and NS398, searching for mechanisms of regulation.
    Stachowicz K; Misztak P; Pańczyszyn-Trzewik P; Lenda T; Rzeźniczek S; Sowa-Kućma M
    Neurochem Int; 2021 Nov; 150():105193. PubMed ID: 34571049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
    Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells.
    Pan MR; Chuang LY; Hung WC
    FEBS Lett; 2001 Nov; 508(3):365-8. PubMed ID: 11728453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
    Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
    J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
    Liu XH; Yao S; Kirschenbaum A; Levine AC
    Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway].
    Huang DS; Xu X; Zheng SS; Cheng JF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):601-5. PubMed ID: 16274041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NS398 protects cells from sodium nitroprusside-mediated cytotoxicity through enhancing HO-1 induction independent of COX-2 inhibition.
    Nizamutdinova IT; Lee JH; Seo HG; Chang KC; Kim HJ
    Arch Pharm Res; 2009 Jan; 32(1):99-107. PubMed ID: 19183882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury.
    Jadhav V; Ostrowski RP; Tong W; Matus B; Jesunathadas R; Zhang JH
    Stroke; 2009 Sep; 40(9):3139-42. PubMed ID: 19628811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
    Li M; Wu X; Xu XC
    Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene.
    Nagayama M; Niwa K; Nagayama T; Ross ME; Iadecola C
    J Cereb Blood Flow Metab; 1999 Nov; 19(11):1213-9. PubMed ID: 10566967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
    Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H
    DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
    Li M; Wu X; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
    Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
    J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.